CHARACTERIZATION OF IN VITRO CYTOXICITY & IN VIVO ANTITUMOR EFFICACY OF IMMUNOTOXIN HERV-K SCFV-RGEL FOR BREAST CANCER
$109,116FY2008Department of DefenseDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center